melanoma

Documents about melanoma

• Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma#871121ClinicalTrials.gov
• Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy#857766ClinicalTrials.gov
• Cytogenetic Study of Ocular Melanoma#853825ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery#828550ClinicalTrials.gov
• CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma#252993ClinicalTrials.gov
• Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery#272359ClinicalTrials.gov
• Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma#343824ClinicalTrials.gov
• Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma#829279ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma#866018ClinicalTrials.gov
• Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy#868701ClinicalTrials.gov
• Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin#651236ClinicalTrials.gov
• Surgery of Melanoma Metastases After Systemic Therapy#444860ClinicalTrials.gov
• Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery#448325ClinicalTrials.gov
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma#866111ClinicalTrials.gov
• RTA 408 Capsules in Patients With Melanoma - REVEAL#377419ClinicalTrials.gov
• Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma#830116ClinicalTrials.gov
• Pembrolizumab and EDP1503 in Advanced Melanoma#307457ClinicalTrials.gov
• Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma#366606ClinicalTrials.gov
• Prospective Melanoma Database#850585ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma#18694ClinicalTrials.gov
• Role of SLURP-1 in Melanoma and Melanoma Stem Cells#803539ClinicalTrials.gov
• Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma#28338ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Melanoma#866226ClinicalTrials.gov
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma#268033ClinicalTrials.gov
• A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma#363609ClinicalTrials.gov
• Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma#807294ClinicalTrials.gov
• Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma#878419ClinicalTrials.gov
• Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma#181589ClinicalTrials.gov
• Neoadjuvant and Adjuvant Checkpoint Blockade#307459ClinicalTrials.gov
• Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma#860228ClinicalTrials.gov
• Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma#300242ClinicalTrials.gov
• Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients#454034ClinicalTrials.gov
• Neoadjuvant Darovasertib in Primary Uveal Melanoma#847861ClinicalTrials.gov
• Comparison of Video-Based Versus Written Patient Education on Melanoma#857597ClinicalTrials.gov
• Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma#880211ClinicalTrials.gov
• Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma#154639ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma#426624ClinicalTrials.gov
• Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma#835453ClinicalTrials.gov
• Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma#279491ClinicalTrials.gov
• Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma#279497ClinicalTrials.gov
• Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery#426650ClinicalTrials.gov
• Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial#683097ClinicalTrials.gov
• Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma#813144ClinicalTrials.gov
• S9804: Vinorelbine in Treating Patients With Stage IV Melanoma#830649ClinicalTrials.gov
• Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma#668852ClinicalTrials.gov
• A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma#432870ClinicalTrials.gov
• Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial#880831ClinicalTrials.gov
• Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma#140979ClinicalTrials.gov
• Neo-adjuvant Immunotherapy in Patients With Localized Melanoma#314324ClinicalTrials.gov
• Definity for Ultrasound of Intraocular Tumors#863137ClinicalTrials.gov

Related topics